C3R is a keratoconus treatment. Keratoconus is a fairly rare condition of the eye where the cornea becomes stretched and begins to form something of a bulge or cone shape where it should usually be round.


Variable settings from 3 mW up to 30 mW with simultaneous radiation time adjustment

  • Continuous, individually customable pulsed and LASIK radiation modes
  • Self-calibrating and self-adjusting
  • Colour touch screen
  • Eye tracking with adjustable real time camera view
  • Bluetooth communication interface with powerful
  • treatment report generation
  • Ultrasound contact pachymeter optional

Corneal Cross-Linking

Corneal cross-linking (CXL)is a treatment with the aim of strengthening the corneal stromal tissue through the formation of new chemical bonds between stromal fibres.



  • CXL is the only effective non-invasive treatment to stop progressive keratoconus as well as related ectatic disorders (such as PMD and iatrogenic ectasia) and has a regularisation effect on corneal topography
  • In addition to its role in treating ectatic corneal diseases, CXL has an established place in the management of infectious keratitis. UV light has long been known for its ability to kill different microorganisms (such as bacterial and fungal ones). Since keratitis in humans is an important cause of blindness, and antibiotic resistance is an increasing problem worldwide, CXL proves to be an extremely valuable possibility to manage the condition with a satisfactory outcome.
  • CXL treatments are inexpensive, easy to perform, and easy for the patient.

Visionary MedTech for a better performance – Swiss Made


Clinical Experience

In recent years corneal cross-linking has become the standard procedure for treating patients with progressive keratoconus and other ectatic corneal diseases because of its effectiveness and lack of serious side effects. A large number of major clinical studies has proven the effectiveness of CXL and the lack of serious side effects. More than 85% of eyes treated with CXL showed a significant increase in BCVA. Six months after the procedure cylinder was reduced in the majority of patients.


Background

Corneal cross-linking is a process of photo polymerization. During this process singlet oxygen is being created with the use of riboflavin as a photo mediator activated by UV light. Free radicals lead to physical intra- and inter-helical cross links of stromal collagen fibres. This process takes place mainly in the anterior 200 μ to 250 μ of the stroma.


The Device

The PXL PLATINUM 330 was designed with a special focus on effectiveness, safety and user friendliness and incorporates the latest clinical experiences. It enables the user to select the required energy levels: 3 mW, 9 mW, 18 mW and 30 mW per cm2 with automatic time adjustment. Furthermore it allows pulsed radiation in connection with the latest experience in treating infectious keratitis, with adjustable illumination on /off intervals. Also dedicated LASIK / PRK modes are available.



PXL PLATINUM 330